Article
Day + 30 detection of minimal residual FLT3-ITD by high-sensitivity PCR-NGS predicts relapse risk and guides post-transplant maintenance in AML.
BMC medicine - 3 Mar 2026
Jiang Shan, Feng Dan, Wan Li, Yang Nan, Ma Jiao, Cao Jiaxin, Pan Pan, Zheng Yawei, Cao Yigeng, Cao Wenbin, Liang Chen, Chen Xin, Zhang Rongli, Ma Qiaoling, Wei Jialin, Zhai Weihua, Yang Donglin, He Yi, Feng Sizhou, Han Mingzhe, Yao Yao, Pang Aiming, Jiang Erlie
Abstract excerpt
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has improved outcomes in patients with acute myeloid leukemia (AML) harboring FLT3-internal tandem duplication (FLT3-ITD) mutations. However, relapse still occurs in 15-35% of these patients after transplantation. Therefore, early and highly sensitive detection methods are required to identify patients at risk of relapse and enable timely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
